About us
Research activity is focused on infectious complications and their association with long-term results of kidney transplantation, and mainly with the incidence of graft rejection. In a long run optimal mode of cytomegalovirus prevention has been evaluated in independent randomized trials with results being incorporated to the International Guidelines. The possibilities of improvement of biocompatibility and anticoagulation therapy during dialysis are assessed in patients with end-stage kidney disease.
Releated Research themes
Contact
I. Medical Department
Faculty of Medicine in Pilsen
alej Svobody 80
301 66 Plzeň
T: 377 103 650
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
Members
- Prof. Tomáš Reischig, M.D., Ph.D. – Research Group Leader
- Mirko Bouda, M.D.
- Assoc. Prof. Jaromír Eiselt, M.D., Ph.D.
- Prof. Ondřej Hes, M.D., Ph.D.
- Pavel Jindra, M.D., Ph.D.
- Martin Kačer, M.D., Ph.D.
- Lenka Karlíková, B.Sc.
- Lukáš Kielberger, M.D., Ph.D.
- Jan Klaboch, M.D., Ph.D.
- Jana Machová, M.D.
- Jana Němcová, Ph.D., M.Sc.
- Martina Putzová, Ph.D., M.Sc.
- Pavlína Richtrová, M.D., Ph.D.
- Tomáš Vaněček, Ph.D., M.Sc.
- Tomáš Vlas, M.Sc.